<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Logan LK</submitter><funding>BLRD VA</funding><funding>NIAID NIH HHS</funding><pagination>595-599</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6440871</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>38(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Fluoroquinolones are uncommonly prescribed in children, yet pediatric multidrug resistant (MDR) enterobacteriaceae (Ent) infections often reveal fluoroquinolone resistance (FQR). We sought to define the molecular epidemiology of FQR and MDR-Ent in children.&lt;h4>Methods&lt;/h4>A case-control analysis of children with MDR-Ent infections at 3 Chicago hospitals was performed. Cases were children with third-generation cephalosporin-resistant and/or carbapenem-resistant Ent infections. Polymerase chain reaction and DNA analysis assessed bla and plasmid-mediated FQR (PMFQR) genes. Controls were children with third-generation cephalosporin, fluoroquinolone, and carbapenem-susceptible Ent infections matched by age, source and hospital. We assessed clinical-epidemiologic predictors of</pubmed_abstract><journal>The Pediatric infectious disease journal</journal><pubmed_title>Community Origins and Regional Differences Highlight Risk of Plasmid-mediated Fluoroquinolone Resistant Enterobacteriaceae Infections in Children.</pubmed_title><pmcid>PMC6440871</pmcid><funding_grant_id>R01 AI063517</funding_grant_id><funding_grant_id>R01 AI100560</funding_grant_id><funding_grant_id>K08 AI112506</funding_grant_id><funding_grant_id>R01 AI072219</funding_grant_id><funding_grant_id>I01 BX001974</funding_grant_id><pubmed_authors>Konda S</pubmed_authors><pubmed_authors>Zheng X</pubmed_authors><pubmed_authors>Qureshi NK</pubmed_authors><pubmed_authors>Rispens JR</pubmed_authors><pubmed_authors>Marshall SH</pubmed_authors><pubmed_authors>Bonomo RA</pubmed_authors><pubmed_authors>Hujer AM</pubmed_authors><pubmed_authors>Rudin SD</pubmed_authors><pubmed_authors>Domitrovic TN</pubmed_authors><pubmed_authors>Logan LK</pubmed_authors><pubmed_authors>Weinstein RA</pubmed_authors><pubmed_authors>Hayden MK</pubmed_authors><pubmed_authors>Medernach RL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Community Origins and Regional Differences Highlight Risk of Plasmid-mediated Fluoroquinolone Resistant Enterobacteriaceae Infections in Children.</name><description>&lt;h4>Background&lt;/h4>Fluoroquinolones are uncommonly prescribed in children, yet pediatric multidrug resistant (MDR) enterobacteriaceae (Ent) infections often reveal fluoroquinolone resistance (FQR). We sought to define the molecular epidemiology of FQR and MDR-Ent in children.&lt;h4>Methods&lt;/h4>A case-control analysis of children with MDR-Ent infections at 3 Chicago hospitals was performed. Cases were children with third-generation cephalosporin-resistant and/or carbapenem-resistant Ent infections. Polymerase chain reaction and DNA analysis assessed bla and plasmid-mediated FQR (PMFQR) genes. Controls were children with third-generation cephalosporin, fluoroquinolone, and carbapenem-susceptible Ent infections matched by age, source and hospital. We assessed clinical-epidemiologic predictors of</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jun</publication><modification>2025-04-18T22:09:25.01Z</modification><creation>2020-06-04T07:02:31Z</creation></dates><accession>S-EPMC6440871</accession><cross_references><pubmed>30281548</pubmed><doi>10.1097/INF.0000000000002205</doi><doi>10.1097/inf.0000000000002205</doi></cross_references></HashMap>